Maiden Pharmaceuticals: Violations, production suspended



Indian well being authorities stated on Wednesday they’d halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and chilly syrups exported to Gambia could also be linked to the deaths of dozens of kids there.

Known as a “pharmacy of the world,” India provides 45% of all generic medicines to Africa.

The deaths of 69 kids in Gambia – one of many worst such incidents involving medication from India – have come as a blow to the trade whose exports greater than doubled within the final decade to hit US$24.5 billion final fiscal yr.

Indian authorities inspected Maiden’s most important manufacturing unit within the state of Haryana 4 occasions this month and stated they suspended all its manufacturing actions on Tuesday after discovering that the agency had been manufacturing and testing medication in violation of guidelines “throughout its manufacturing and testing actions.”

“In view of the seriousness of the contraventions noticed in the course of the investigation and its potential danger to the standard, security and efficacy of the drug being produced, all of the manufacturing actions of the agency is being stopped with speedy impact,” stated an order by federal and Haryana state drug regulators.

Maiden government Naresh Kumar Goyal declined to remark.

The medication exported to Gambia had been made by Maiden in a single batch in December final yr at its most important manufacturing unit in Haryana’s Sonipat district, about 40 kms (25 miles) north of New Delhi, with a use-by-date of November, 2024, the order stated.

A high Indian well being official, who declined to be named, stated the federal government wouldn’t tolerate wrongdoing however that it was essential to seek out out what precisely occurred in Gambia. He denied allegations by some critics that well being laws in India, particularly on the stage of states, had been lax.

The authorities has fashioned a committee of 4 consultants that can advise additional motion after “inspecting and analyzing opposed occasion studies, causal relationship and all associated particulars shared by the WHO (World Health Organization).”

Indian legal guidelines permit for imprisonment and fines for promoting spurious medication.

But the supply stated the WHO had but to share any report establishing a direct hyperlink to the deaths with the Indian-made medicines.

WHO Assistant Director-General Mariângela Simão advised a digital information convention it was working carefully with Indian authorities to research Maiden’s cough and chilly syrups.

She stated the WHO’s conclusion in regards to the deaths being linked to Maiden’s medicines was primarily based on evaluation of a number of samples of medicines that had been utilized by hospitalized kids.


Maiden says on its web site it has an annual production capability of two.2 million syrup bottles, 600 million capsules, 18 million injections, 300,000 ointment tubes and 1.2 billion tablets at its Haryana factories. It says it has two different factories within the state other than the principle one.

The WHO issued a medical product alert final week asking regulators to take away Maiden items from the market.

The UN well being company stated that laboratory evaluation of 4 Maiden merchandise – Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup – had “unacceptable” quantities of diethylene glycol and ethylene glycol, which may be toxic and result in acute kidney damage.

Diethylene glycol and ethylene glycol are used as a less expensive various in some pharmaceutical merchandise to glycerine, a solvent or thickening agent in lots of cough syrups.

Gambian police, in a preliminary investigation report on Tuesday, stated that the deaths of 69 kids from acute kidney damage was linked to the cough syrups made in India and imported by way of Atlanta-based Atlantic Pharmaceuticals.

Atlantic couldn’t be reached for remark.

The cough syrups had been permitted for export solely to Gambia, India says, though the WHO says they might have gone elsewhere by means of casual markets.

Indonesia stated on Wednesday it might examine instances of acute kidney damage which has induced the deaths of greater than 20 kids in its capital Jakarta this yr, however that there was no reference to the instances in Gambia.

Reporting by Tanvi Mehta and Krishna Das; Additional reporting by Manas Mishra; Editing by Raju Gopalakrishnan, Kirsten Donovan, Alex Richardson and Emelia Sithole-Matarise


Please enter your comment!
Please enter your name here